Raymond James & Associates’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.83M Buy
55,313
+23,387
+73% +$1.57M ﹤0.01% 2008
2024
Q2
$2.02M Buy
31,926
+1,804
+6% +$108K ﹤0.01% 2169
2024
Q1
$1.99M Sell
30,122
-3,681
-11% -$299K ﹤0.01% 2162
2023
Q4
$3.32M Sell
33,803
-36,223
-52% -$3.16M ﹤0.01% 1786
2023
Q3
$5.61M Buy
70,026
+56,901
+434% +$4.46M ﹤0.01% 1385
2023
Q2
$1.06M Sell
13,125
-5,993
-31% -$560K ﹤0.01% 2436
2023
Q1
$2.32M Sell
19,118
-4,232
-18% -$575K ﹤0.01% 1941
2022
Q4
$3.11M Sell
23,350
-1,948
-8% -$237K ﹤0.01% 1727
2022
Q3
$2.82M Sell
25,298
-2,886
-10% -$369K ﹤0.01% 1753
2022
Q2
$3.82M Sell
28,184
-6,131
-18% -$923K ﹤0.01% 1584
2022
Q1
$5.72M Sell
34,315
-5,731
-14% -$1.09M ﹤0.01% 1417
2021
Q4
$7.15M Sell
40,046
-13,334
-25% -$2.38M 0.01% 1299
2021
Q3
$9.45M Sell
53,380
-611
-1% -$101K 0.01% 1084
2021
Q2
$8.68M Sell
53,991
-13,709
-20% -$2.11M 0.01% 1154
2021
Q1
$10.1M Buy
67,700
+1,028
+2% +$125K 0.01% 1028
2020
Q4
$6.58M Buy
+66,672
New +$6.66M 0.01% 1182

Other funds holding CNXC

Raymond James & Associates's CNXC Position: Q3 2024 in Review

Raymond James & Associates increased its Concentrix (CNXC) stake by 73% in Q3 2024, buying an estimated $1.57M and bringing the position to 55,313 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Raymond James & Associates first reported a position in CNXC in Q4 2020 and has held it in 16 quarters since. The position peaked at $10.1M in Q1 2021. 284 funds tracked by Wall St. Rank hold CNXC as of Q3 2024.

  • Raymond James & Associates held 55,313 shares of Concentrix worth $2.83M as of Q3 2024.
  • Raymond James & Associates bought 23,387 Concentrix shares in Q3 2024, an estimated $1.57M.
  • Concentrix made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2008 holding.
  • Raymond James & Associates first reported a position in Concentrix in Q4 2020 and has held it in 16 quarters since.
  • Raymond James & Associates's Concentrix position peaked at $10.1M in Q1 2021.
  • 284 funds tracked by Wall St. Rank held Concentrix as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.